RecruitingNCT06675851
Antidepressants, brain dopamine and reward in depression
About this title
Read the official source — NCT06675851Medication studyAges 18–65Austria
Understand this study
Who could participate?
This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- ViennaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 1, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- Medical University of Vienna
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Austria
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06675851
- Official title
Show the full official title
Reward-specific Changes of Cerebral Dopamine Synthesis in Healthy Volunteers and Depressed Patients
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vienna
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of Vienna, a university.
Does this study involve medication?
Yes. The study involves medication, including WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline and Cipralex (escitalopram).
Who can participate?
This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
